$REAL
TheRealReal, Inc. Stock $real

$real Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000157322123000048 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$130.9M	$141.9M
YoY Change	-15.27%	-3.27%
Cost Of Revenue	$44.68M	$51.92M
YoY Change	-33.06%	-23.74%
Gross Profit	$86.17M	$89.98M
YoY Change	-1.73%	14.46%
Gross Profit Margin	65.85%	63.41%
Selling, General & Admin	$44.33M	$49.85M
YoY Change	-68.03%	3.28%
% of Gross Profit	51.44%	55.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.965M	$7.821M
YoY Change	18.95%	22.89%
% of Gross Profit	9.24%	8.69%
Operating Expenses	$127.1M	$171.8M
YoY Change	-8.33%	28.85%
Operating Profit	-$40.94M	-$81.80M
YoY Change	-19.69%	49.52%
Interest Expense	$2.678M	$2.667M
YoY Change	-210.89%	0.11%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Pretax Income	-$41.22M	-$82.41M
YoY Change	-22.43%	43.55%
Income Tax	$114.0K	$86.00K
% Of Pretax Income
Net Earnings	-$41.33M	-$82.50M
YoY Change	-22.26%	43.7%
Net Earnings / Revenue	-31.58%	-58.14%
Basic Earnings Per Share	-$0.41	-$0.83
Diluted Earnings Per Share	-$0.41	-$0.83
COMMON SHARES
Basic Shares Outstanding	100.2M shares	99.25M shares
Diluted Shares Outstanding	101.0M shares	99.61M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$188.9M	$247.1M
YoY Change	-40.2%	-31.54%
Cash & Equivalents	$188.9M	$247.1M
Short-Term Investments
Other Short-Term Assets	$18.87M	$24.20M
YoY Change	-8.93%	13.2%
Inventory	$25.90M	$30.84M
Prepaid Expenses
Receivables	$5.994M	$8.941M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$239.7M	$311.1M
YoY Change	-42.53%	-32.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$105.8M	$101.9M
YoY Change	-53.73%	12.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.468M	$3.160M
YoY Change	95.99%	-3.25%
Total Long-Term Assets	$219.1M	$200.6M
YoY Change	-5.34%	-14.33%
TOTAL ASSETS
Total Short-Term Assets	$239.7M	$311.1M
Total Long-Term Assets	$219.1M	$200.6M
Total Assets	$458.7M	$511.8M
YoY Change	-29.26%	-26.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.15M	$8.867M
YoY Change	63.35%	40.92%
Accrued Expenses	$61.84M	$72.11M
YoY Change	-59.93%	5.04%
Deferred Revenue	$1.872M	$3.528M
YoY Change		7.2%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$168.0M	$183.9M
YoY Change	-2.46%	2.31%
LONG-TERM LIABILITIES
Long-Term Debt	$451.1M	$450.5M
YoY Change	0.63%	0.63%
Other Long-Term Liabilities	$3.071M	$3.297M
YoY Change	-97.73%	57.07%
Total Long-Term Liabilities	$3.071M	$3.297M
YoY Change	-99.47%	57.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$168.0M	$183.9M
Total Long-Term Liabilities	$3.071M	$3.297M
Total Liabilities	$734.3M	$755.3M
YoY Change	-2.81%	-1.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.075B	-$1.034B
YoY Change		27.28%
Common Stock	$1.000K	$1.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$275.6M	-$243.5M
YoY Change
Total Liabilities & Shareholders Equity	$458.7M	$511.8M
YoY Change	-29.26%	-26.73%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$41.33M	-$82.50M
YoY Change	-22.26%	43.7%
Depreciation, Depletion And Amortization	$7.965M	$7.821M
YoY Change	18.95%	22.89%
Cash From Operating Activities	-$30.42M	-$30.43M
YoY Change	-21.08%	-38.34%
INVESTING ACTIVITIES
Capital Expenditures	$11.36M	$11.71M
YoY Change	-246.14%	127.61%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$11.36M	-$15.92M
YoY Change	46.14%	88.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	333.0K	-$295.0K
YoY Change	-72.37%	-146.31%
NET CHANGE
Cash From Operating Activities	-30.42M	-$30.43M
Cash From Investing Activities	-11.36M	-$15.92M
Cash From Financing Activities	333.0K	-$295.0K
Net Change In Cash	-41.45M	-$46.65M
YoY Change	-8.13%	-18.4%
FREE CASH FLOW
Cash From Operating Activities	-$30.42M	-$30.43M
Capital Expenditures	$11.36M	$11.71M
Free Cash Flow	-$41.78M	-$42.14M
YoY Change	35.76%	-22.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TheRealReal, Inc.
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001573221
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	City Area Code CityAreaCode	855
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	435-5893
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38953
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1234222
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Francisco Street
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94133
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	REAL
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	100174285	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	247145000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293793000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8941000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12207000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	30843000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	42967000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24202000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23291000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	311131000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	372258000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101876000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112679000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95587000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127955000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3160000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2749000	usd
CY2023Q1	us-gaap	Assets Assets	511754000	usd
CY2022Q4	us-gaap	Assets Assets	615641000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8867000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11902000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	72114000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81543000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20691000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20776000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82271000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93292000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	183943000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	207513000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	117553000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	125118000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	450481000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	449848000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3297000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3254000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	755274000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	785733000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100152432	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100152432	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99088172	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99088172	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	790132000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	781060000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1033653000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951153000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-243520000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	511754000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	615641000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	141904000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	146700000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	51921000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	68083000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	89983000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	78617000	usd
CY2023Q1	us-gaap	Marketing Expense MarketingExpense	17518000	usd
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	17961000	usd
CY2023Q1	real	Operations And Technology Expense OperationsAndTechnologyExpense	68032000	usd
CY2022Q1	real	Operations And Technology Expense OperationsAndTechnologyExpense	67101000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49845000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48262000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	36388000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	171783000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	133324000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-81800000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-54707000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2053000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	98000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2667000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2664000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-139000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-82414000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57412000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82500000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57412000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99608071	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99608071	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93476106	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93476106	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-208000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9280000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-82500000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-243520000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	637000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12964000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-57412000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-69317000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-82500000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-57412000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7821000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6364000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8991000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12514000	usd
CY2023Q1	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	5172000	usd
CY2022Q1	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	4797000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	651000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	193000	usd
CY2023Q1	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	575000	usd
CY2022Q1	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	575000	usd
CY2023Q1	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	633000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3655000	usd
CY2022Q1	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	641000	usd
CY2023Q1	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-36000	usd
CY2022Q1	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-175000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	32891000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	3446000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	1809000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2615000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	602000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8678000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4492000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1139000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	426000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	461000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	779000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6158000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1385000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2030000	usd
CY2023Q1	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-9429000	usd
CY2022Q1	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-2389000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-894000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-8627000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	24000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-70000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30433000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49354000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	4214000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	3304000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11706000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5143000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15920000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8447000	usd
CY2023Q1	real	Inventory Adjustments Provisions For Write Down And Shrinkage InventoryAdjustmentsProvisionsForWriteDownAndShrinkage	3400000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	637000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	295000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-295000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	637000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-46648000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57164000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418171000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	247145000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361007000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1458000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1448000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1906000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	718000	usd
CY2023Q1	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1279000	usd
CY2022Q1	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1838000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	290000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	450000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, standalone selling price related to revenue transactions, valuation of inventory, software development costs, stock-based compensation, incremental borrowing rates related to lease liability, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2022 Form 10-K. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2022 Form 10-K for a complete summary of our significant accounting policies.</span></div>
CY2022Q1	real	Inventory Adjustments Provisions For Write Down And Shrinkage InventoryAdjustmentsProvisionsForWriteDownAndShrinkage	1800000	usd
CY2023Q1	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	4600000	usd
CY2022Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	6100000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, and accounts receivable. At times, such amount may exceed federally-insured limits. The Company is closely monitoring ongoing events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally. The Company reduces credit risk by placing its cash and cash equivalents, and investments with major financial institutions with high credit ratings within the United States. The Company has not experienced any realized losses on cash and cash equivalents to date; however, no assurances can be provided.</span></div>As of March 31, 2023 and December 31, 2022, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the three months ended March 31, 2023 and 2022.
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	247145000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	247145000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293793000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	293793000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	161327000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	175814000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59451000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63135000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101876000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112679000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7500000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6400000	usd
CY2023Q1	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7200000	usd
CY2023Q1	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	18839000	usd
CY2022Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	22233000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	16606000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	15111000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	2110000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	484000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	7469000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8531000	usd
CY2023Q1	real	Site Credit Liability SiteCreditLiability	14366000	usd
CY2022Q4	real	Site Credit Liability SiteCreditLiability	11813000	usd
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8053000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8729000	usd
CY2023Q1	real	Accrued Shipping AccruedShipping	3350000	usd
CY2022Q4	real	Accrued Shipping AccruedShipping	5715000	usd
CY2023Q1	real	Accrued Fixed Asset Purchases AccruedFixedAssetPurchases	1446000	usd
CY2022Q4	real	Accrued Fixed Asset Purchases AccruedFixedAssetPurchases	11417000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3528000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3549000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1741000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	usd
CY2023Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4763000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4544000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82271000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93292000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8991000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12514000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	300000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	500000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7100000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7200000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1300000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1500000	usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	25700000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	21350000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28073000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28213000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27772000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21410000	usd
CY2023Q1	real	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	38033000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164851000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	26607000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	138244000	usd
CY2023Q1	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	8231000	usd
CY2022Q1	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	6101000	usd
CY2023Q1	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurements Due To Lease Modification RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementsDueToLeaseModification	-1493000	usd
CY2022Q1	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurements Due To Lease Modification RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementsDueToLeaseModification	25000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	flagship_store
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	neighborhood_store
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	consignment_office
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	36400000	usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	25700000	usd
CY2023Q1	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7200000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	1700000	usd
CY2023Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1800000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	258200000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2400000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-82500000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82500000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57412000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-57412000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99608071	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99608071	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93476106	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93476106	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38991927	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31537233	shares

Files In Submission

Name	View Source	Status
real-20230331_htm.xml	Edgar Link	completed
0001573221-23-000048-index-headers.html	Edgar Link	pending
0001573221-23-000048-index.html	Edgar Link	pending
0001573221-23-000048.txt	Edgar Link	pending
0001573221-23-000048-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
real-20230331.htm	Edgar Link	pending
real-20230331.xsd	Edgar Link	pending
real-2023331xex311.htm	Edgar Link	pending
real-2023331xex312.htm	Edgar Link	pending
real-2023331xex321.htm	Edgar Link	pending
real-2023331xex322.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
real-20230331_cal.xml	Edgar Link	unprocessable
real-20230331_def.xml	Edgar Link	unprocessable
real-20230331_pre.xml	Edgar Link	unprocessable
real-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REAL
TheRealReal, Inc. Stock $real

2023 Q2 Form 10-Q Financial Statement

#000157322123000048 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL TheRealReal, Inc. Stock $real

2023 Q2 Form 10-Q Financial Statement

#000157322123000048 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL
TheRealReal, Inc. Stock $real